Michal McDowell1,2, Dana J Pardee3, Sarah Peitzmeier3,4, Sari L Reisner3,5,6, Madina Agénor7, Natalie Alizaga8, Ida Bernstein1, Jennifer Potter1,3,9. 1. 1 Harvard Medical School , Boston, Massachusetts. 2. 2 Department of Health Policy and Management, Harvard T.H. Chan School of Public Health , Boston, Massachusetts. 3. 3 The Fenway Institute , Fenway Health, Boston, Massachusetts. 4. 4 Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland. 5. 5 Division of General Pediatrics, Boston Children's Hospital/Harvard Medical School , Boston, Massachusetts. 6. 6 Department of Epidemiology, Harvard T.H. Chan School of Public Health , Boston, Massachusetts. 7. 7 Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health , Boston, Massachusetts. 8. 8 Department of Psychology, The George Washington University , Washington, District of Columbia. 9. 9 Department of Medicine, Beth Israel Deaconess Medical Center , Boston, Massachusetts.
Abstract
PURPOSE: Trans-masculine (TM, i.e., persons who have a masculine spectrum gender identity, but were assigned female sex at birth) individuals face disparities in cervical cancer screening rates compared to cisgender women. Some unique barriers to screening in this population are specific to Pap tests. Introduction of self-collected frontal (i.e., vaginal) swabs for human papillomavirus (HPV) testing as a screening strategy may obviate these barriers. This study elucidates cervical cancer screening preferences among TM individuals. METHODS: TM individuals participated in in-depth interviews (n = 31) and online surveys (n = 32) to explore perceptions and experiences regarding cervical cancer screening, including the acceptability of self-collected frontal HPV swabs for cervical cancer screening compared to provider-administered Pap tests. Provider-collected frontal HPV swab acceptability was also explored. RESULTS: Most TM individuals (94% in-person and 91% online participants) preferred either the self- or provider-collected frontal HPV swab to the Pap test. Participants perceived self- and provider-collected frontal HPV swabs to be less invasive, provoke less gender discordance, and promote a greater sense of agency compared to Pap tests. However, some participants expressed concern about HPV swab accuracy and, regarding the self-collected swab, discomfort about the need to engage with genitals they may not want to acknowledge. Individuals who reported positive provider relationships found Pap tests and provider-collected frontal swabs more acceptable than those who did not. CONCLUSION: Frontal HPV swabs have the potential to promote regular cervical cancer screening among TM individuals and to narrow screening disparities. Work is ongoing to establish swab accuracy and develop shared decision-making tools.
PURPOSE: Trans-masculine (TM, i.e., persons who have a masculine spectrum gender identity, but were assigned female sex at birth) individuals face disparities in cervical cancer screening rates compared to cisgender women. Some unique barriers to screening in this population are specific to Pap tests. Introduction of self-collected frontal (i.e., vaginal) swabs for human papillomavirus (HPV) testing as a screening strategy may obviate these barriers. This study elucidates cervical cancer screening preferences among TM individuals. METHODS: TM individuals participated in in-depth interviews (n = 31) and online surveys (n = 32) to explore perceptions and experiences regarding cervical cancer screening, including the acceptability of self-collected frontal HPV swabs for cervical cancer screening compared to provider-administered Pap tests. Provider-collected frontal HPV swab acceptability was also explored. RESULTS: Most TM individuals (94% in-person and 91% online participants) preferred either the self- or provider-collected frontal HPV swab to the Pap test. Participants perceived self- and provider-collected frontal HPV swabs to be less invasive, provoke less gender discordance, and promote a greater sense of agency compared to Pap tests. However, some participants expressed concern about HPV swab accuracy and, regarding the self-collected swab, discomfort about the need to engage with genitals they may not want to acknowledge. Individuals who reported positive provider relationships found Pap tests and provider-collected frontal swabs more acceptable than those who did not. CONCLUSION: Frontal HPV swabs have the potential to promote regular cervical cancer screening among TM individuals and to narrow screening disparities. Work is ongoing to establish swab accuracy and develop shared decision-making tools.
Entities:
Keywords:
HPV; Pap test; cervical cancer; health screening; sexually transmitted infections; trans masculine
Authors: Sari L Reisner; Renee K Randazzo; Jaclyn M White Hughto; Sarah Peitzmeier; L Zachary DuBois; Dana J Pardee; Elliot Marrow; Sarah McLean; Jennifer Potter Journal: Qual Health Res Date: 2017-05-04
Authors: Caitlin B Biddell; Meghan C O'Leary; Stephanie B Wheeler; Lisa P Spees Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-26 Impact factor: 4.254
Authors: Carolyn Moloney; Margaret Allen; Derek G Power; Richard M Bambury; Deirdre O'Mahony; Dearbhaile M O'Donnell; Seamus O'Reilly; Dearbhaile C Collins Journal: Oncologist Date: 2020-12-19
Authors: Sarah M Peitzmeier; Ida M Bernstein; Michal J McDowell; Dana J Pardee; Madina Agénor; Natalie M Alizaga; Sari L Reisner; Jennifer Potter Journal: Cult Health Sex Date: 2019-10-29
Authors: Elizabeth Cathcart-Rake; Jennifer O'Connor; Jennifer L Ridgeway; Carmen Radecki Breitkopf; Judith S Kaur; Jessica Mitchell; Konstantinos Leventakos; Aminah Jatoi Journal: Am J Hosp Palliat Care Date: 2020-03-26 Impact factor: 2.500
Authors: Alison M Berner; Dean J Connolly; Imogen Pinnell; Aedan Wolton; Adriana MacNaughton; Chloe Challen; Kate Nambiar; Jacob Bayliss; James Barrett; Christina Richards Journal: Br J Gen Pract Date: 2021-07-29 Impact factor: 6.302